New cochlear implant requires no external hardware

Cochlear implants - medical devices that electrically stimulate the auditory nerve - have granted at least limited hearing to hundreds of thousands of people worldwide who otherwise would be totally deaf. Existing versions of the device, however, require that a disk-shaped transmitter about an inch in diameter be affixed to the skull, with a wire snaking down to a joint microphone and power source that looks like an oversized hearing aid around the patient's ear.

Researchers at MIT's Microsystems Technology Laboratory (MTL), together with physicians from Harvard Medical School and the Massachusetts Eye and Ear Infirmary (MEEI), have developed a new, low-power signal-processing chip that could lead to a cochlear implant that requires no external hardware. The implant would be wirelessly recharged and would run for about eight hours on each charge.

The researchers describe their chip in a paper they're presenting this week at the International Solid-State Circuits Conference. The paper's lead author - Marcus Yip, who completed his PhD at MIT last fall - and his colleagues Rui Jin and Nathan Ickes, both graduate students in MIT's Department of Electrical Engineering and Computer Science, will also exhibit a prototype charger that plugs into an ordinary cell phone and can recharge the signal-processing chip in roughly two minutes.

"The idea with this design is that you could use a phone, with an adaptor, to charge the cochlear implant, so you don't have to be plugged in," says Anantha Chandrakasan, the Joseph F. and Nancy P. Keithley Professor of Electrical Engineering and corresponding author on the new paper. "Or you could imagine a smart pillow, so you charge overnight, and the next day, it just functions."

Adaptive reuse

Existing cochlear implants use an external microphone to gather sound, but the new implant would instead use the natural microphone of the middle ear, which is almost always intact in cochlear-implant patients.

The researchers' design exploits the mechanism of a different type of medical device, known as a middle-ear implant. Delicate bones in the middle ear, known as ossicles, convey the vibrations of the eardrum to the cochlea, the small, spiral chamber in the inner ear that converts acoustic signals to electrical. In patients with middle-ear implants, the cochlea is functional, but one of the ossicles - the stapes - doesn't vibrate with enough force to stimulate the auditory nerve. A middle-ear implant consists of a tiny sensor that detects the ossicles' vibrations and an actuator that helps drive the stapes accordingly.

The new device would use the same type of sensor, but the signal it generates would travel to a microchip implanted in the ear, which would convert it to an electrical signal and pass it on to an electrode in the cochlea. Lowering the power requirements of the converter chip was the key to dispensing with the skull-mounted hardware.

Chandrakasan's lab at MTL specializes in low-power chips, and the new converter deploys several of the tricks that the lab has developed over the years, such as tailoring the arrangement of low-power filters and amplifiers to the precise acoustic properties of the incoming signal.

But Chandrakasan and his colleagues also developed a new signal-generating circuit that reduces the chip's power consumption by an additional 20 to 30 percent. The key was to specify a new waveform - the basic electrical signal emitted by the chip, which is modulated to encode acoustic information - that is more power-efficient to generate but still stimulates the auditory nerve in the appropriate way.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Long-term low-dose antiviral treatment reduces eye disease risk from shingles